| Liporox vs Jin | 86–84 | 50.59% |
| Liporox vs King | 83–75 | 52.53% |
| Liporox vs Law | 79–52 | 60.31% |
| Liporox vs Hwoarang | 61–68 | 47.29% |
| Liporox vs Bryan | 57–57 | 50.00% |
| Liporox vs Heihachi | 40–73 | 35.40% |
| Liporox vs Reina | 46–50 | 47.92% |
| Liporox vs Eddy | 44–49 | 47.31% |
| Liporox vs Nina | 47–40 | 54.02% |
| Liporox vs Kazuya | 42–40 | 51.22% |
| Liporox vs Lili | 36–36 | 50.00% |
| Liporox vs Xiaoyu | 40–31 | 56.34% |
| Liporox vs Azucena | 35–33 | 51.47% |
| Liporox vs Dragunov | 32–34 | 48.48% |
| Liporox vs Paul | 18–40 | 31.03% |
| Liporox vs Steve | 33–25 | 56.90% |
| Liporox vs Devil Jin | 22–34 | 39.29% |
| Liporox vs Yoshimitsu | 26–23 | 53.06% |
| Liporox vs Jun | 23–23 | 50.00% |
| Liporox vs Leo | 21–23 | 47.73% |
| Liporox vs Lee | 17–25 | 40.48% |
| Liporox vs Asuka | 20–21 | 48.78% |
| Liporox vs Lars | 14–27 | 34.15% |
| Liporox vs Raven | 14–27 | 34.15% |
| Liporox vs Leroy | 25–13 | 65.79% |
| Liporox vs Alisa | 12–24 | 33.33% |
| Liporox vs Feng | 14–15 | 48.28% |
| Liporox vs Zafina | 18–11 | 62.07% |
| Liporox vs Victor | 12–17 | 41.38% |
| Liporox vs Shaheen | 16–11 | 59.26% |
| Liporox vs Lidia | 13–11 | 54.17% |
| Liporox vs Kuma | 9–14 | 39.13% |
| Liporox vs Jack-8 | 9–13 | 40.91% |
| Liporox vs Claudio | 8–8 | 50.00% |
| Liporox vs Panda | 0–1 | 0.00% |
| Liporox vs Clive | 0–1 | 0.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.